The presence of LPS in the microbiota of lymphoma patients interacted with TNF signaling and enhanced the NF-κB pathway through MyD88-dependent TLR4 signaling, leading to increased survival and proliferation of intestinal B cells. The gene discussed is TNF; the disease is lymphoma.